Page last updated: 2024-10-18

dihydroxyphenylalanine and Dysautonomia

dihydroxyphenylalanine has been researched along with Dysautonomia in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Goyal, H1
Sharma, A1
Patel, C1
Deepak, KK1
Tripathi, M1
Gupta, P1
Kumar, R1
Bal, CS1
Goyal, V1

Other Studies

1 other study available for dihydroxyphenylalanine and Dysautonomia

ArticleYear
Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:3

    Topics: Aged; Dihydroxyphenylalanine; Feasibility Studies; Female; Heart Diseases; Humans; Male; Middle Aged

2022